Cargando…
SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
Objective: This study aimed to investigate the role of squamous cell carcinoma antigen recognized by T cells 3 (SART3) in hepatocellular carcinoma (HCC). Methods: SART3 expression and prognostic value were analyzed in TCGA and GEO datasets. The diagnostic value and prognostic significance of SART3 w...
Autores principales: | Nong, Jusen, Yang, Kejian, Li, Tianman, Lan, Chenlu, Zhou, Xin, Liu, Junqi, Xie, Haixiang, Luo, Jianzhu, Liao, Xiwen, Zhu, Guangzhi, Peng, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496991/ https://www.ncbi.nlm.nih.gov/pubmed/37632835 http://dx.doi.org/10.18632/aging.204978 |
Ejemplares similares
-
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
por: Zhou, Xin, et al.
Publicado: (2022) -
Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma
por: Xie, Haixiang, et al.
Publicado: (2023) -
RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
por: Wei, Yongguang, et al.
Publicado: (2023) -
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
por: Wei, Yongguang, et al.
Publicado: (2023) -
PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Lan, Chenlu, et al.
Publicado: (2023)